Xufen Yu

2.4k total citations
45 papers, 1.5k citations indexed

About

Xufen Yu is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Xufen Yu has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 9 papers in Hematology and 8 papers in Organic Chemistry. Recurrent topics in Xufen Yu's work include Protein Degradation and Inhibitors (25 papers), Ubiquitin and proteasome pathways (15 papers) and Multiple Myeloma Research and Treatments (8 papers). Xufen Yu is often cited by papers focused on Protein Degradation and Inhibitors (25 papers), Ubiquitin and proteasome pathways (15 papers) and Multiple Myeloma Research and Treatments (8 papers). Xufen Yu collaborates with scholars based in United States, China and Japan. Xufen Yu's co-authors include Dianqing Sun, Jian Jin, Xiyan Lu, Yudao Shen, Jing Liu, Jing Liu, Ling Cai, Gang Greg Wang, Xian Chen and Kwang‐Su Park and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Xufen Yu

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xufen Yu United States 24 1.1k 393 286 183 56 45 1.5k
Philipp M. Cromm Germany 14 1.6k 1.4× 355 0.9× 467 1.6× 248 1.4× 31 0.6× 19 1.7k
Swen Hoelder United Kingdom 16 1.1k 1.0× 390 1.0× 246 0.9× 226 1.2× 56 1.0× 22 1.5k
Vassilios Bavetsias United Kingdom 21 1.0k 0.9× 597 1.5× 471 1.6× 132 0.7× 49 0.9× 54 1.7k
Paul Fleming United States 12 958 0.9× 395 1.0× 455 1.6× 271 1.5× 33 0.6× 23 1.4k
Hon‐Wah Man United States 17 784 0.7× 412 1.0× 277 1.0× 459 2.5× 32 0.6× 24 1.5k
David M. Ryckman United States 18 1.3k 1.2× 423 1.1× 413 1.4× 75 0.4× 51 0.9× 31 1.8k
Henrik C. Hansen United States 15 890 0.8× 267 0.7× 121 0.4× 294 1.6× 23 0.4× 43 1.2k
Angelo Aguilar United States 17 1.3k 1.1× 419 1.1× 699 2.4× 195 1.1× 74 1.3× 28 1.8k
Juiwanna Kushner United States 22 697 0.6× 389 1.0× 140 0.5× 228 1.2× 42 0.8× 31 1.1k

Countries citing papers authored by Xufen Yu

Since Specialization
Citations

This map shows the geographic impact of Xufen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufen Yu more than expected).

Fields of papers citing papers by Xufen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufen Yu. The network helps show where Xufen Yu may publish in the future.

Co-authorship network of co-authors of Xufen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xufen Yu. A scholar is included among the top collaborators of Xufen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufen Yu. Xufen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manzari, Mandana T., Xufen Yu, Quincey LaPlant, et al.. (2025). Tumor microenvironment–targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors. Science Advances. 11(49). eadu2292–eadu2292.
2.
Yu, Xufen, Bo Pan, Ho Man Chan, et al.. (2025). Pharmacologic degradation of WDR5 suppresses oncogenic activities of SS18::SSX and provides a therapeutic of synovial sarcoma. Science Advances. 11(17). eads7876–eads7876. 2 indexed citations
3.
Lin, Ying‐Hung, Jing Liu, Xiaohe Tian, et al.. (2025). Design, synthesis, and biological evaluation of novel BTK-targeting proteolysis targeting chimeras (PROTACs) with enhanced pharmacokinetic properties. European Journal of Medicinal Chemistry. 289. 117420–117420. 1 indexed citations
4.
Kabir, Md, Xufen Yu, H. Ümit Kanıskan, & Jian Jin. (2023). Chemically induced degradation of epigenetic targets. Chemical Society Reviews. 52(13). 4313–4342. 18 indexed citations
5.
Wang, Li, Ling Xie, Feng Zhang, et al.. (2023). Non-canonical function of histone methyltransferase G9a in the translational regulation of chronic inflammation. Cell chemical biology. 30(12). 1525–1541.e7. 6 indexed citations
6.
Yu, Xufen, Jun Wang, Weida Gong, et al.. (2023). Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader. Oncogene. 42(13). 994–1009. 16 indexed citations
7.
Schwalm, Martin P., Andreas Krämer, Xufen Yu, et al.. (2023). Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization. Cell chemical biology. 30(7). 753–765.e8. 35 indexed citations
8.
Chen, Song, Zhendong Chen, Yunpeng Zhao, et al.. (2023). Discovery of novel BTK PROTACs with improved metabolic stability via linker rigidification strategy. European Journal of Medicinal Chemistry. 255. 115403–115403. 24 indexed citations
9.
Wang, Jun, Kwang‐Su Park, Xufen Yu, et al.. (2022). A cryptic transactivation domain of EZH2 binds AR and AR’s splice variant, promoting oncogene activation and tumorous transformation. Nucleic Acids Research. 50(19). 10929–10946. 26 indexed citations
10.
Cai, Wesley L., Huacui Chen, Sarah J. Kurley, et al.. (2022). Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation. eLife. 11. 14 indexed citations
11.
Liu, Jing, Xufen Yu, He Chen, et al.. (2022). TF-DUBTACs Stabilize Tumor Suppressor Transcription Factors. Journal of the American Chemical Society. 144(28). 12934–12941. 42 indexed citations
12.
Dale, Brandon, Kwang‐Su Park, H. Ümit Kanıskan, et al.. (2022). Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2. ACS Pharmacology & Translational Science. 5(7). 491–507. 32 indexed citations
13.
Li, Dongxu, Xufen Yu, Jithesh Kottur, et al.. (2022). Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic. Oncogene. 41(24). 3328–3340. 31 indexed citations
14.
Yu, Xufen, Jithesh Kottur, Yudao Shen, et al.. (2021). A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. Science Translational Medicine. 13(613). eabj1578–eabj1578. 91 indexed citations
15.
Pu, Hong, José Silva, Idan Cohen, et al.. (2021). UV-induced reduction in Polycomb repression promotes epidermal pigmentation. Developmental Cell. 56(18). 2547–2561.e8. 15 indexed citations
16.
Li, Jie, Phillip M. Galbo, Weida Gong, et al.. (2021). ZMYND11-MBTD1 induces leukemogenesis through hijacking NuA4/TIP60 acetyltransferase complex and a PWWP-mediated chromatin association mechanism. Nature Communications. 12(1). 1045–1045. 28 indexed citations
17.
Shen, Yudao, Guozhen Gao, Xufen Yu, et al.. (2020). Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders. Journal of Medicinal Chemistry. 63(17). 9977–9989. 69 indexed citations
18.
Prior, Allan M., Xufen Yu, Eun‐Jung Park, et al.. (2017). Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1. Bioorganic & Medicinal Chemistry Letters. 27(24). 5393–5399. 23 indexed citations
19.
Yu, Xufen, Mingming Zhang, Thirunavukkarasu Annamalai, et al.. (2016). Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors. European Journal of Medicinal Chemistry. 125. 515–527. 17 indexed citations
20.
Yu, Xufen, Eun‐Jung Park, Tamara P. Kondratyuk, John M. Pezzuto, & Dianqing Sun. (2012). Synthesis of 2-arylindole derivatives and evaluation as nitric oxide synthase and NFκB inhibitors. Organic & Biomolecular Chemistry. 10(44). 8835–8835. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philipp M. Cromm Breakdown of academic impact, for papers by Swen Hoelder Breakdown of academic impact, for papers by Vassilios Bavetsias Breakdown of academic impact, for papers by Paul Fleming Breakdown of academic impact, for papers by Hon‐Wah Man Breakdown of academic impact, for papers by David M. Ryckman Breakdown of academic impact, for papers by Henrik C. Hansen Breakdown of academic impact, for papers by Angelo Aguilar Breakdown of academic impact, for papers by Juiwanna Kushner
Rankless by CCL
2026